Treatment with lamivudine versus lamivudine and thymosin alpha-1 for e antigen-positive chronic hepatitis B patients: a meta-analysis
<p>Abstract</p> <p>Background</p> <p>Currently, there is no evidence on the combination of lamivudine and thymosin alpha-1 on chronic hepatitis B patients. The aim of this study was to compare the effect of lamivudine monotherapy with that of lamivudine and thymosin alp...
Main Authors: | Yang Jin, Chen En-Qiang, Zhang Yuan-Yuan, Duan Yu-Rong, Tang Hong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-05-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/6/1/63 |
Similar Items
-
Efficacy of lamivudine and thymosin alpha-1 combination therapy in treatment of HBeAg-positive chronic hepatitis B: a meta-analysis
by: QI Youtao
Published: (2014-07-01) -
Meta-analysis: Adefovir dipivoxil in combination with lamivudine in patients with lamivudine-resistant hepatitis B virus
by: Wang Li-Chun, et al.
Published: (2009-10-01) -
Comparison of tenofovir plus lamivudine versus tenofovir monotherapy in patients with lamivudine-resistant chronic hepatitis B
by: Chan Ho Park, et al.
Published: (2016-03-01) -
Initial combining lamivudine and adefovir dipivoxil and lamivudine/entecavir monotherapy in hepatitis B e antigen-positive chronic hepatitis B with high viral load
by: J. You, et al.
Published: (2014-04-01) -
Lamivudine plus adefovir combination therapy versus entecavir monotherapy for lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysis
by: Hu Peng, et al.
Published: (2011-08-01)